The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
AACR 2021 | Future treatment landscape for colon cancer
Giacomo Bregni, MD, Jules Bordet Institute, Brussels, Belgium, shares his views on how treatment strategies for colon and colorectal cancer will evolve over the next few years, highlighting results from the FOxTROT trial (NCT00647530) and the potential role of immune checkpoint inhibitors in the future. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
